Contrasting association of circulating sCD14 with insulin sensitivity in non-obese and morbidly obese subjects

Barbora de Courten, José Maria Moreno-Navarrete, Jasmine Lyons, Georgia Soldatos, Maximilian de Courten, Sonia L Dougherty, Josephine Forbes, José Manuel Fernández-Real

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Scope: In experimental studies, moderate to high concentrations of sCD14 (serum cluster of differentiation 14 protein) prevent lipopolysaccharide (LPS)-induced systemic inflammation, while low concentrations may promote inflammation. Given that metabolic endotoxemia is thought to initiate high-fat diet-induced insulin resistance, we explored the association between sCD14 concentrations and insulin sensitivity in humans. Methods and results: Healthy non-obese (n = 12, BMI 26 ± 5y), obese (n = 11, BMI 33.45 ± 3.2) and morbidly obese participants (n = 38, BMI 45 ± 7) underwent measurement of body composition (dual energy X-ray absorptiometry) and a hyperinsulinemic-euglycemic clamp to measure insulin sensitivity (M value). Circulating sCD14 concentrations were measured by ELISA. Non-obese participants had lower circulating sCD14 concentrations compared to obese (p = 0.03). Circulating sCD14 concentrations were positively associated with percent body fat, waist circumference and white blood cell count and negatively associated with insulin sensitivity. In contrast, circulating sCD14 were positively associated with insulin sensitivity in morbidly obese participants. In regression analysis, insulin sensitivity (r = 0.52, p = 0.004) and fasting triglycerides (r = 0.49, p = 0.005) contributed independently to circulating sCD14 variance after controlling for age, sex and BMI in these morbidly obese subjects. Conclusion: These findings suggest that circulating sCD14 concentrations, through its compensatory (in non-obese subjects) or buffering role (in morbidly obese subjects), could exert an important role in modulating insulin sensitivity.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalMolecular Nutrition and Food Research
Volume60
Issue number1
DOIs
Publication statusPublished - 1 Jan 2016

Keywords

  • Adiposity
  • CD14
  • Fitness
  • Insulin resistance
  • Obesity

Cite this

de Courten, Barbora ; Moreno-Navarrete, José Maria ; Lyons, Jasmine ; Soldatos, Georgia ; de Courten, Maximilian ; Dougherty, Sonia L ; Forbes, Josephine ; Fernández-Real, José Manuel. / Contrasting association of circulating sCD14 with insulin sensitivity in non-obese and morbidly obese subjects. In: Molecular Nutrition and Food Research. 2016 ; Vol. 60, No. 1. pp. 103-109.
@article{2170467bf2784dfb809c0bfd85c5d3c3,
title = "Contrasting association of circulating sCD14 with insulin sensitivity in non-obese and morbidly obese subjects",
abstract = "Scope: In experimental studies, moderate to high concentrations of sCD14 (serum cluster of differentiation 14 protein) prevent lipopolysaccharide (LPS)-induced systemic inflammation, while low concentrations may promote inflammation. Given that metabolic endotoxemia is thought to initiate high-fat diet-induced insulin resistance, we explored the association between sCD14 concentrations and insulin sensitivity in humans. Methods and results: Healthy non-obese (n = 12, BMI 26 ± 5y), obese (n = 11, BMI 33.45 ± 3.2) and morbidly obese participants (n = 38, BMI 45 ± 7) underwent measurement of body composition (dual energy X-ray absorptiometry) and a hyperinsulinemic-euglycemic clamp to measure insulin sensitivity (M value). Circulating sCD14 concentrations were measured by ELISA. Non-obese participants had lower circulating sCD14 concentrations compared to obese (p = 0.03). Circulating sCD14 concentrations were positively associated with percent body fat, waist circumference and white blood cell count and negatively associated with insulin sensitivity. In contrast, circulating sCD14 were positively associated with insulin sensitivity in morbidly obese participants. In regression analysis, insulin sensitivity (r = 0.52, p = 0.004) and fasting triglycerides (r = 0.49, p = 0.005) contributed independently to circulating sCD14 variance after controlling for age, sex and BMI in these morbidly obese subjects. Conclusion: These findings suggest that circulating sCD14 concentrations, through its compensatory (in non-obese subjects) or buffering role (in morbidly obese subjects), could exert an important role in modulating insulin sensitivity.",
keywords = "Adiposity, CD14, Fitness, Insulin resistance, Obesity",
author = "{de Courten}, Barbora and Moreno-Navarrete, {Jos{\'e} Maria} and Jasmine Lyons and Georgia Soldatos and {de Courten}, Maximilian and Dougherty, {Sonia L} and Josephine Forbes and Fern{\'a}ndez-Real, {Jos{\'e} Manuel}",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/mnfr.201500102",
language = "English",
volume = "60",
pages = "103--109",
journal = "Molecular Nutrition and Food Research",
issn = "1613-4125",
publisher = "Wiley-Blackwell",
number = "1",

}

Contrasting association of circulating sCD14 with insulin sensitivity in non-obese and morbidly obese subjects. / de Courten, Barbora; Moreno-Navarrete, José Maria; Lyons, Jasmine; Soldatos, Georgia; de Courten, Maximilian; Dougherty, Sonia L; Forbes, Josephine; Fernández-Real, José Manuel.

In: Molecular Nutrition and Food Research, Vol. 60, No. 1, 01.01.2016, p. 103-109.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Contrasting association of circulating sCD14 with insulin sensitivity in non-obese and morbidly obese subjects

AU - de Courten, Barbora

AU - Moreno-Navarrete, José Maria

AU - Lyons, Jasmine

AU - Soldatos, Georgia

AU - de Courten, Maximilian

AU - Dougherty, Sonia L

AU - Forbes, Josephine

AU - Fernández-Real, José Manuel

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Scope: In experimental studies, moderate to high concentrations of sCD14 (serum cluster of differentiation 14 protein) prevent lipopolysaccharide (LPS)-induced systemic inflammation, while low concentrations may promote inflammation. Given that metabolic endotoxemia is thought to initiate high-fat diet-induced insulin resistance, we explored the association between sCD14 concentrations and insulin sensitivity in humans. Methods and results: Healthy non-obese (n = 12, BMI 26 ± 5y), obese (n = 11, BMI 33.45 ± 3.2) and morbidly obese participants (n = 38, BMI 45 ± 7) underwent measurement of body composition (dual energy X-ray absorptiometry) and a hyperinsulinemic-euglycemic clamp to measure insulin sensitivity (M value). Circulating sCD14 concentrations were measured by ELISA. Non-obese participants had lower circulating sCD14 concentrations compared to obese (p = 0.03). Circulating sCD14 concentrations were positively associated with percent body fat, waist circumference and white blood cell count and negatively associated with insulin sensitivity. In contrast, circulating sCD14 were positively associated with insulin sensitivity in morbidly obese participants. In regression analysis, insulin sensitivity (r = 0.52, p = 0.004) and fasting triglycerides (r = 0.49, p = 0.005) contributed independently to circulating sCD14 variance after controlling for age, sex and BMI in these morbidly obese subjects. Conclusion: These findings suggest that circulating sCD14 concentrations, through its compensatory (in non-obese subjects) or buffering role (in morbidly obese subjects), could exert an important role in modulating insulin sensitivity.

AB - Scope: In experimental studies, moderate to high concentrations of sCD14 (serum cluster of differentiation 14 protein) prevent lipopolysaccharide (LPS)-induced systemic inflammation, while low concentrations may promote inflammation. Given that metabolic endotoxemia is thought to initiate high-fat diet-induced insulin resistance, we explored the association between sCD14 concentrations and insulin sensitivity in humans. Methods and results: Healthy non-obese (n = 12, BMI 26 ± 5y), obese (n = 11, BMI 33.45 ± 3.2) and morbidly obese participants (n = 38, BMI 45 ± 7) underwent measurement of body composition (dual energy X-ray absorptiometry) and a hyperinsulinemic-euglycemic clamp to measure insulin sensitivity (M value). Circulating sCD14 concentrations were measured by ELISA. Non-obese participants had lower circulating sCD14 concentrations compared to obese (p = 0.03). Circulating sCD14 concentrations were positively associated with percent body fat, waist circumference and white blood cell count and negatively associated with insulin sensitivity. In contrast, circulating sCD14 were positively associated with insulin sensitivity in morbidly obese participants. In regression analysis, insulin sensitivity (r = 0.52, p = 0.004) and fasting triglycerides (r = 0.49, p = 0.005) contributed independently to circulating sCD14 variance after controlling for age, sex and BMI in these morbidly obese subjects. Conclusion: These findings suggest that circulating sCD14 concentrations, through its compensatory (in non-obese subjects) or buffering role (in morbidly obese subjects), could exert an important role in modulating insulin sensitivity.

KW - Adiposity

KW - CD14

KW - Fitness

KW - Insulin resistance

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84952977970&partnerID=8YFLogxK

U2 - 10.1002/mnfr.201500102

DO - 10.1002/mnfr.201500102

M3 - Article

VL - 60

SP - 103

EP - 109

JO - Molecular Nutrition and Food Research

JF - Molecular Nutrition and Food Research

SN - 1613-4125

IS - 1

ER -